Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Inactive Ingredient Disclosure Expansion In House User Fee Bill Poised For Changes
May 11 2022
•
By
Derrick Gingery
Rep. Fred Upton, R-MI, debates the inactive ingredient provision in the House user fee reauthorization bill. • Source: screenshot
More from Generics
More from Biosimilars & Generics